helplinedonate
  • Announcements

    • ForumAdmin

      Frequently Asked Questions - Step by step guides

      Do you need assistance registering, logging in, posting, etc? Please visit the all new Frequently Asked Question Forum for step-by-step guides. Click the link below to access these helpful guides. Frequently Asked Questions
    • ForumAdmin

      Recursos Nuevos en Español

      http://www.parkinson.org/ayuda   http://www.parkinson.org/espanol    
    • ForumAdmin

      Línea de Ayuda 1-800-473-4636

      Línea de Ayuda 1-800-473-4636   ¿Qué es la línea de ayuda 1-800-4PD-INFO (473-4636) de la Fundación Nacional de Parkinson? Es un número de teléfono gratuito que ayuda a las personas con la enfermedad de Parkinson, sus familiares, amigos y profesionales de salud, a solucionar diferentes inquietudes.   La línea de ayuda ofrece: Información actualizada Apoyo emocional Referidos a profesionales de salud Recursos comunitarios Amplia variedad de publicaciones gratis    
kholden

FDA approves Vanderbilt trial for Parkinson’s treatment

5 posts in this topic

FDA approves Vanderbilt trial for Parkinson’s treatment

Tom Wilemon, twilemon@tennessean.com 10:12 p.m. CDT April 4, 2014
-dr.davidcharles.jpg20081107.jpg

(Photo: handout)

SHARECONNECTTWEETCOMMENTEMAILMORE

Parkinson’s disease researchers at Vanderbilt University have gotten the go-ahead from the U.S. Food and Drug Administration to expand a trial of a new treatment using deep brain stimulation.

The phase III trial will recruit 350 patients at 15 academic medical centers in the United States and Europe, according to a press release issued Friday by Vanderbilt University Medical Center.

“This research has been decades in the making, and we are so excited to receive this approval to expand the trial,” said Dr. David Charles, the chief medical officer of the Vanderbilt Neuroscience Institute. “Our hypothesis is that patients who have deep brain stimulation applied in the very early stage of Parkinson’s disease will do much better in quality of life and motor function and have delayed onset of disability and medication-associated complications. Expanding the trial will help test that hypothesis.”

Parkinson’s disease is believed to affect as many as 7 million people worldwide, according to the press release.

To learn more about the trial, contact Vanderbilt University Medical Center at 615-343-2961.

Reach Tom Wilemon at 615-726-5961 and on Twitter @TomWilemon.

 

http://www.tennessean.com/story/news/health/2014/04/04/fda-approves-vanderbilt-trial-parkinsons-treatment/7335175/

1 person likes this

Share this post


Link to post
Share on other sites

Nice looking doctor. :-P   Forgot what the article was about. haha

 

 

 

LOL! You made me go back and take a second look -- you're right!

Edited by Kathrynne Holden, MS

Share this post


Link to post
Share on other sites

Ms Holden:

Thank you for this post. I have called the center and left my contact information in the hopes I may be considered in the trial. Your efforts in behalf of this forum is very appreciated.

 

I was diagnosed last August, but find my tremors are increasing and my cognitive function deteriorating rapidly, so I am willing to take part in a trial in the hopes I may abate the progress.

 

You are to be commended in providing new info such as this to members of our forum, without which we would have little access to what is developing for us.

Share this post


Link to post
Share on other sites

New Normal, that is what the forum is for, to help in any way we can. I am always grateful when I can help at all. I very much hope you will be included in the trial, and please do let us know the result if you are.

Share this post


Link to post
Share on other sites